[go: up one dir, main page]

DE60318327D1 - Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe - Google Patents

Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe

Info

Publication number
DE60318327D1
DE60318327D1 DE60318327T DE60318327T DE60318327D1 DE 60318327 D1 DE60318327 D1 DE 60318327D1 DE 60318327 T DE60318327 T DE 60318327T DE 60318327 T DE60318327 T DE 60318327T DE 60318327 D1 DE60318327 D1 DE 60318327D1
Authority
DE
Germany
Prior art keywords
resveratrol
medicament
manufacture
fluid
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60318327T
Other languages
English (en)
Other versions
DE60318327T2 (de
Inventor
Enrico Garaci
Anna T Palamara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of DE60318327D1 publication Critical patent/DE60318327D1/de
Publication of DE60318327T2 publication Critical patent/DE60318327T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60318327T 2002-11-06 2003-10-14 Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe Expired - Lifetime DE60318327T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000562A ITRM20020562A1 (it) 2002-11-06 2002-11-06 Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.
ITRM20020562 2002-11-06
PCT/IT2003/000626 WO2004041260A1 (en) 2002-11-06 2003-10-14 Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections

Publications (2)

Publication Number Publication Date
DE60318327D1 true DE60318327D1 (de) 2008-02-07
DE60318327T2 DE60318327T2 (de) 2008-12-18

Family

ID=32310188

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60318327T Expired - Lifetime DE60318327T2 (de) 2002-11-06 2003-10-14 Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe

Country Status (18)

Country Link
US (1) US8431617B2 (de)
EP (1) EP1567137B1 (de)
JP (1) JP4589118B2 (de)
KR (1) KR101060331B1 (de)
AR (1) AR041891A1 (de)
AT (1) ATE381929T1 (de)
AU (1) AU2003279551A1 (de)
CA (1) CA2504872C (de)
CY (1) CY1107302T1 (de)
DE (1) DE60318327T2 (de)
DK (1) DK1567137T3 (de)
ES (1) ES2295660T3 (de)
IT (1) ITRM20020562A1 (de)
MX (1) MXPA05004628A (de)
PL (1) PL217628B1 (de)
PT (1) PT1567137E (de)
TW (1) TWI337863B (de)
WO (1) WO2004041260A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2626056A1 (en) * 2005-11-18 2007-05-24 Ares Trading S.A. Interferon in influenza
CA2717119A1 (en) * 2008-03-06 2009-11-12 Mount Sinai School Of Medicine Of New York University Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof
WO2010053949A1 (en) * 2008-11-04 2010-05-14 Metaproteomics, Llc Phytochemical compositions and methods for activating amp-kinase
WO2010123527A2 (en) * 2008-12-19 2010-10-28 The Regents Of The University Of California Use of epidermal growth factor inhibitors in the treatment of viral infection
KR100950445B1 (ko) 2009-10-26 2010-04-02 주식회사 중앙백신연구소 감초로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제
WO2011150413A1 (en) 2010-05-28 2011-12-01 Mount Sinai School Of Medicine Antiviral compounds and uses thereof
WO2013049773A1 (en) * 2011-09-30 2013-04-04 Vanderbilt University Antiviral therapies with phospholipase d inhibitors
EP2952209B1 (de) 2014-06-04 2018-03-28 Alfasigma S.p.A. Homogene Formulierungen mit mehrfach ungesättigten Omega-3-Fettsäuren (n-3 PUFA) und Resveratrol zur oralen Verabreichung
ES2615630T3 (es) 2014-06-04 2017-06-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Formulaciones sólidas que contienen resveratrol y ácidos grasos poliinsaturados omega-3 (n-3 PUFA)
EP3120842A1 (de) * 2015-07-20 2017-01-25 Opterion Health AG Peritoneale therapeutische flüssigkeit
KR20170039456A (ko) 2015-10-01 2017-04-11 동아대학교 산학협력단 오동나무로부터 추출한 ｃ-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물
JP2018024592A (ja) * 2016-08-09 2018-02-15 株式会社ブレインヘルス 抗生物質含有組成物
CN108893558B (zh) * 2018-05-24 2022-04-05 江苏海宏制药有限公司 一种桑木液原液抗病毒实验方法以及装置
WO2021207094A1 (en) * 2020-04-05 2021-10-14 Mong Michael Systems and methods for treating coronavirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2778337B1 (fr) 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures
PE20010540A1 (es) * 1999-07-30 2001-05-15 Procter & Gamble Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza
EP1207907B1 (de) 1999-08-13 2004-11-03 University Of Maryland Biotechnology Institute Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür

Also Published As

Publication number Publication date
EP1567137A1 (de) 2005-08-31
KR101060331B1 (ko) 2011-08-30
CA2504872A1 (en) 2004-05-21
MXPA05004628A (es) 2005-09-08
WO2004041260A1 (en) 2004-05-21
TWI337863B (en) 2011-03-01
JP2006507295A (ja) 2006-03-02
JP4589118B2 (ja) 2010-12-01
DE60318327T2 (de) 2008-12-18
ATE381929T1 (de) 2008-01-15
TW200501935A (en) 2005-01-16
US20050239906A1 (en) 2005-10-27
ES2295660T3 (es) 2008-04-16
ITRM20020562A1 (it) 2004-05-07
CY1107302T1 (el) 2012-11-21
CA2504872C (en) 2011-07-05
US8431617B2 (en) 2013-04-30
AR041891A1 (es) 2005-06-01
PL377557A1 (pl) 2006-02-06
AU2003279551A1 (en) 2004-06-07
DK1567137T3 (da) 2008-04-28
PT1567137E (pt) 2008-02-19
EP1567137B1 (de) 2007-12-26
KR20050071627A (ko) 2005-07-07
PL217628B1 (pl) 2014-08-29

Similar Documents

Publication Publication Date Title
ATE390407T1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
DE60230425D1 (de) Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
DE50209278D1 (de) Vorrichtung zur Behandlung einer medizinischen Flüssigkeit
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
ATE550338T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
DE60328476D1 (de) Medizinisches ballonsystem zur behandlung von adipositas
EP1534074A4 (de) Kombinationstherapie zur behandlung von fettleibigkeit
NO20033594L (no) Fenetanolamin-derivater for behandling av luftveissykdommer
DE60318327D1 (de) Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe
DE602004029465D1 (de) Externes Präparat zur Behandlung von Fusspilz
NO20045554L (no) Fremgangsmate for behandling av diabetes
ATE510536T1 (de) Verwendung von 2,5-dihydroxybenzol-derivaten zur behandlung von reaktiven gewebeerkrankungen
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
DE602006002608D1 (de) 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
DE50209948D1 (de) Verwendung von Scopinester Derivaten zur Herstellung von Arzneimitteln
DE502005002324D1 (de) Reaktor zur behandlung hochviskoser kunststoffschmelzen
DE602005019341D1 (de) System zur Behandlung von Sterilisationskassetten mit visuellem Dual-Kode Leser
DE60128911D1 (de) Verwendung von l-threo-methylphenidat zur herstellung eines medikamentes zur behandlung von psychischen erkrankungen
DE502004004324D1 (de) Maschine zur Behandlung eines Gleises
DE602006018822D1 (de) Verwendung des Agomelatins zur Herstellung eines Medikamentes zur Behandlung der bipolaren Erkrankungen
DE602005000442D1 (de) Verwendung von alpha-1-Antitrypsin zur Herstellung eines Medikaments zur Behandlung von Fibromyalgie

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: GARACI, ENRICO, I-00040 POMEZIA, IT

Inventor name: PALAMARA, ANNA T., I-00040 POMEZIA, IT

8364 No opposition during term of opposition